Vittorio Bellomarino | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Ponatinib alone or with chemo-immunotherapy in heavily pre-treated Philadelphia-like acute lymphoblastic leukemia: a CAMPUS ALL real-life study	HAEMATOLOGICA	2024
DROPLET DIGITAL PCR DETECTION OF THE T315I BCR::ABL1 KD MUTATION IN ADULT PH-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA	European Hematology Association (EHA) 2023 Open Library	2023
Research Topic: Measurable Residual Disease in Hematologic Malignancies. Can digital droplet {PCR} improve measurable residual disease monitoring in chronic lymphoid malignancies?	FRONTIERS IN ONCOLOGY	2023
Digital droplet PCR for T315I BCR::ABL1 KD mutation assessment in adult Ph-positive acute lymphoblastic leukemia with a minimal residual disease increase	LEUKEMIA & LYMPHOMA	2023
Optimizing Molecular Minimal Residual Disease Analysis in Adult Acute Lymphoblastic Leukemia	CANCERS	2023
Optimizing Molecular Minimal Residual Disease Analysis in Adult Acute Lymphoblastic Leukemia	CANCERS	2023
Digital Droplet PCR Is a Reliable Tool to Improve Minimal Residual Disease Stratification in Adult Philadelphia-Negative Acute Lymphoblastic Leukemia	THE JOURNAL OF MOLECULAR DIAGNOSTICS	2022
Circulating cell‐free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre‐analytical biases	HEMATOLOGICAL ONCOLOGY	2022
Digital Droplet PCR for Minimal Residual Disease Assessment in Philadelphia-Positive Acute Lymphoblastic Leukemia Using IG/TR Genes and BCR/ABL1 as Markers. Preliminary Results of a Comparative Analysis	BloodBLOOD	2022

KET

Life-science technologies & biotechnologies

Interessi di ricerca

Hematology
Genetics
Cancer
Research
Molecular biology

Keywords

hematological diseases

hematological disorders

research

cancer

molecular biology

genetics

next generation sequencing

acute lymphoblastic leukemia

minimal residual disease

Molecular diagnosis

Mantle cell lymphoma

DLBCL

follicular lymphoma

Molecular characterization